Clinical Trial Update: Effect of Magnesium Alginate on Gastroesophageal Reflux in Infants. [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial assesses whether magnesium alginate reduces gastroesophageal reflux in infants; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Magnesium alginate (magnesium alginate)

Snippet

Sponsor: Policlinico Hospital | Conditions: Gastroesophageal Reflux | Phase 4 | Status: UNKNOWN